GMAB

$53.631.69%0.89

After Hours: 53.89+0.26 +0.48%

Genmab Adr (GMAB)

Genmab Adr Stock (GMAB) Forecast

The Genmab Adr (GMAB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $48.26, representing a -10.01% decrease from the current price of $53.63. The highest analyst price target is $50.52, and the lowest is $46.01.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month GMAB Price Target

Average 43.57 (-18.75% Downside)

Is Genmab Adr (GMAB) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	70.70	Sell
STOCH(9,6)	71.98	Neutral
STOCHRSI(14)	20.48	Neutral
MACD(12,26)	5.06	Buy
ADX(14)	46.71	Buy
William %R	-29.41	Neutral
CCI(14)	33.09	Neutral

Buy: 2 · Sell: 1 · Neutral: 4Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	53.21 Buy	51.99 Buy
MA20	45.94 Buy	47.87 Buy
MA50	39.18 Buy	41.31 Buy
MA100	34.32 Buy	36.67 Buy
MA200	31.05 Buy	33.04 Buy

Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, GMAB could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 1 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on GMAB, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 70.70 indicates that GMAB is overbought. This suggests that GMAB price has experienced a significant increase over a specified lookback period, potentially leading to a correction.
STOCH (Stochastic Oscillator): The STOCH value of 71.98 indicates that GMAB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 20.48 indicates that GMAB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 46.71 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 33.09 indicates that GMAB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term GMAB price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Genmab Adr financial reports and earnings history, Genmab Adr (GMAB) stock could reach $39.42 by 2030, $75.60 by 2040 and $100.82 by 2050. See the projected annual prices until 2050 of the Genmab Adr stock below:

Genmab Adr (GMAB) is expected to reach an average price of $45.03 in 2035, with a high prediction of $54.43 and a low estimate of $43.53. This indicates an -16.03% change from the last recorded price of $53.63.
Genmab Adr (GMAB) stock is projected to chart a bullish course in 2040, with an average price target of $63.74, representing an +18.84% change from its current level. The forecast ranges from a conservative $60.02 to a sky-high $75.60.
Our analysts predict Genmab Adr (GMAB) to change +48.05% by 2045, soaring from $77.82 to an average price of $79.40, potentially reaching $90.16. While $77.82 is the low estimate, the potential upside is significant.
Genmab Adr (GMAB) stock is expected to climb by 2050, reaching an average of $90.62, a +68.98% change from its current level. However, a wide range of estimates exists, with high and low targets of $100.82 and $78.39, respectively, highlighting the market's uncertainty.

Genmab Adr Stock (GMAB) Year by Year Forecast

Genmab Adr Stock (GMAB) Price Forecast for 2026

The predicted value for Genmab Adr (GMAB) in 2026 is set at an average of $35.21. Estimates vary from a peak of $59.97 to a trough of $23.62, indicating an -34.34% surge from the present price of $53.63.

Month	Average	Low	High	Change from today's price
December, 2026	$49.90	$46.01	$50.52	-6.96%

Genmab Adr Stock (GMAB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Genmab Adr (GMAB) is $44.93, with a high forecast of $50.57 and a low forecast of $36.63. This indicates an -16.22% decrease from the last price of $53.63.

Month	Average	Low	High	Change from today's price
January, 2027	$43.74	$43.59	$50.46	-18.44%
February, 2027	$43.59	$41.85	$45.65	-18.72%
March, 2027	$42.02	$40.37	$44.96	-21.65%
April, 2027	$46.98	$42.65	$48.01	-12.39%
May, 2027	$41.19	$41.04	$49.05	-23.19%
June, 2027	$40.67	$37.81	$41.54	-24.17%
July, 2027	$42.76	$36.63	$42.79	-20.27%
August, 2027	$46.17	$41.49	$46.79	-13.92%
September, 2027	$46.41	$44.87	$48.68	-13.46%
October, 2027	$47.99	$44.84	$48.23	-10.51%
November, 2027	$47.09	$41.98	$48.14	-12.19%
December, 2027	$50.57	$45.71	$50.57	-5.70%

Genmab Adr Stock (GMAB) Price Forecast for 2028

In 2028, Genmab Adr (GMAB) is projected to reach an average price of $50.47, with a high projection of $58.16 and a low estimate of $45.44. This indicates an -5.90% fall from the last price of $53.63.

Month	Average	Low	High	Change from today's price
January, 2028	$57.72	$49.73	$58.16	+7.63%
February, 2028	$53.08	$52.51	$57.80	-1.03%
March, 2028	$49.60	$49.17	$54.37	-7.52%
April, 2028	$50.76	$48.75	$50.89	-5.35%
May, 2028	$46.65	$45.44	$50.60	-13.01%
June, 2028	$52.41	$46.61	$52.47	-2.27%
July, 2028	$52.51	$50.28	$53.84	-2.08%
August, 2028	$49.46	$49.43	$53.29	-7.78%
September, 2028	$48.62	$47.74	$50.44	-9.35%
October, 2028	$48.39	$48.30	$53.68	-9.78%
November, 2028	$49.30	$46.73	$50.54	-8.07%
December, 2028	$47.12	$47.02	$49.83	-12.14%

Genmab Adr Stock (GMAB) Price Forecast for 2029

The 2029 price forecast for Genmab Adr Stock (GMAB) is $40.39 on average, with a high prediction of $47.76 and a low estimate of $35.94. This represents an -24.68% decrease from the previous price of $53.63.

Month	Average	Low	High	Change from today's price
January, 2029	$39.50	$39.12	$47.76	-26.34%
February, 2029	$43.91	$38.84	$44.00	-18.12%
March, 2029	$43.43	$41.33	$44.00	-19.03%
April, 2029	$42.80	$40.98	$44.07	-20.20%
May, 2029	$39.02	$38.51	$41.19	-27.25%
June, 2029	$39.02	$37.55	$40.71	-27.24%
July, 2029	$41.20	$39.66	$43.15	-23.18%
August, 2029	$39.47	$38.75	$41.80	-26.40%
September, 2029	$41.33	$38.75	$41.76	-22.93%
October, 2029	$37.42	$36.77	$41.42	-30.22%
November, 2029	$39.18	$35.94	$39.30	-26.95%
December, 2029	$38.42	$37.50	$40.00	-28.37%

Genmab Adr Stock (GMAB) Price Forecast for 2030

Genmab Adr Stock (GMAB) is expected to reach an average price of $33.36 in 2030, with a high forecast of $39.42 and a low forecast of $29.01. This signifies an -37.80% decrease from the last price of $53.63.

Month	Average	Low	High	Change from today's price
January, 2030	$38.40	$37.78	$39.42	-28.40%
February, 2030	$35.02	$34.77	$38.28	-34.70%
March, 2030	$33.88	$33.78	$35.29	-36.82%
April, 2030	$33.10	$31.94	$35.06	-38.27%
May, 2030	$32.66	$31.48	$33.95	-39.11%
June, 2030	$32.47	$31.56	$33.94	-39.46%
July, 2030	$34.05	$30.34	$34.26	-36.51%
August, 2030	$31.50	$31.37	$36.05	-41.26%
September, 2030	$31.82	$29.01	$32.12	-40.67%
October, 2030	$31.17	$31.16	$33.57	-41.87%
November, 2030	$34.04	$30.71	$34.06	-36.52%
December, 2030	$32.18	$32.11	$34.98	-39.99%

Similar to GMAB